Nutrition and Physical Activity in Optimizing Weight Loss and Lean Mass Preservation in the Incretin-Based Medications Era: A Narrative Review.

Luisa Barana, Michelantonio De Fano, Massimiliano Cavallo, Marcello Manco, Deborah Prete, Carmine Giuseppe Fanelli, Francesca Porcellati, Roberto Pippi

Journal: Nutrients 2026;18(1):

PMID: 41515247

Abstract

BACKGROUND/OBJECTIVES

Incretin-based medications have transformed obesity management by enabling substantial body weight reduction. However, the rapid and pronounced loss of body mass necessitates a comprehensive, multidisciplinary approach incorporating nutritional and physical activity strategies to preserve lean mass, optimize functional outcomes, and prevent long-term complications. This narrative review provides a critical overview of this emerging clinical concern, which is expected to gain increasing relevance in the coming years.

METHODS

A literature review was conducted up to 31 October 2025, focusing on studies addressing nutritional, physical activity, and adjunctive interventions in adults with obesity treated with incretin-based medications.

RESULTS

Incretin-based agents induce significant weight loss, comparable to bariatric surgery, predominantly targeting adipose tissue. Nevertheless, these medications also cause rapid reductions in muscle and bone mass, often accompanied by nutrient deficiencies, which may compromise metabolic health and physical function. Tailored nutritional strategies-including hypocaloric diets enriched in protein and fiber, as well as amino acid, vitamin, and mineral supplementation-are critical to preserve lean mass and support sustained weight maintenance. Concurrently, structured, supervised physical activity, encompassing aerobics, resistance, and strength training, mitigates muscle loss and enhances functional capacity. Emerging pharmacological agents designed to promote adipose tissue reduction while preserving lean mass, as well as interventions targeting gut microbiota modulation, may represent promising adjunctive strategies to optimize long-term outcomes further.

CONCLUSIONS

While incretin-based medications produce substantial weight loss, their impact on lean mass underscores the necessity of integrating personalized nutrition, supplementation, and structured exercise to preserve muscle, prevent malnutrition, and optimize long-term health and obesity outcomes.

Address: Diabetology and Endocrinology, Degli Infermi New Hospital of Biella, 13875 Ponderano, Italy.; Endocrine and Metabolic Sciences Section, Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy.; Internal Medicine and Vascular Diseases Unit, Azienda Ospedaliera Santa Maria, 05100 Terni, Italy.; Healthy Lifestyle Institute, Centro Universitario Ricerca Interdipartimentale Attività Motoria (C.U.R.I.A.Mo.), Department of Medicine and Surgery, University of Perugia, Via G. Bambagioni, 19, 06126 Perugia, Italy.; Healthy Lifestyle Institute, Centro Universitario Ricerca Interdipartimentale Attività Motoria (C.U.R.I.A.Mo.), Department of Medicine and Surgery, University of Perugia, Via G. Bambagioni, 19, 06126 Perugia, Italy.; Department of Medicine and Surgery, Perugia University Medical School, 06126 Perugia, Italy.; Department of Medicine and Surgery, Perugia University Medical School, 06126 Perugia, Italy.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.